21 research outputs found
Carboxymethylchitosan/poly (amidoamine) dendrimer nanoparticles in central nervous systems-regenerative medicine: effects on neuron/glial cell viability and internalization efficiency
The applicability of CMCht/PAMAM dendrimer nanoparticles for CNS applications was
investigated. AFM and TEM observations revealed that the nanoparticles possessed a nanosphere-
like shape with a size from 22.0 to 30.7 nm. The nanoparticles could be bound to
fluorescent-probe FITC for tracing purposes. Post-natal hippocampal neurons and cortical glial
cells were both able to internalize the FITC-labeled
CMCht/PAMAM dendrimer nanoparticles with
high efficiency. The percentage of positive cells
internalizing the nanoparticles varied, reaching a
peak after 48 h of incubation. Further experiments
for periods up to 7 d revealed that the
periodical addition of FITC-labelled CMCht/
PAMAM dendrimer nanoparticles was needed to
maintain the overall percentage of cells internalizing
them. Finally, it was also observed that cell
viability was not significantly affected by the
incubation of dendrimer nanoparticles.Financial support from the Portuguese Foundation for Science and Technology through funds from POCTI and/or FEDER programs (Funding to ICVS, 3B's Research Group, post-doctoral and pre-doctoral fellowships to A.J. Salgado and J.M. Oliveira - SFRH/BPD/17595/2004; SFRH/BD/21786/2005) is gratefully acknowledged. This work was also carried out under the scope of the European NoE EXPERTISSUES (NMP3-CT-2004-500283) and HIPPOCRATES STREP (NMP3-CT-2003-505758) projects
Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world
Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic.
Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality.
Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States.
Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis.
Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection